Ruprecht-Karls-Universität Heidelberg

University / College


Location: Heidelberg, Germany (DE) DE

ISNI: 0000000121904373

ROR: https://ror.org/038t36y30

Show on Map:


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Associations of individual factors and early childhood education and care (ECEC) centres characteristics with preschoolers’ BMI in Germany (2022) Herr RM, De Bock F, Diehl K, Wiedemann E, Sterdt E, Blume M, Hoffmann S, et al. Journal article Homogenization of a nonlinear drift-diffusion system for multiple charged species in a porous medium (2022) Bhattacharya A, Gahn M, Neuss-Radu M Journal article DMBT1 is upregulated in cystic fibrosis, affects ciliary motility, and is reduced by acetylcysteine (2022) Kiefer A, Plattner E, Ruppel R, Weiss C, Zhou-Suckow Z, Mall M, Renner M, Müller H Journal article Sex-specific association between prenatal androgenization (second-to-fourth digit length ratio) and frontal brain volumes in adolescents (2022) Lenz B, Gerhardt S, Boroumand-Jazi R, Eichler A, Buchholz VN, Fasching P, Kornhuber J, et al. Journal article Reply to Martin and Dauby (2022) Kling K, Domingo C, Bogdan C, Wilder-Smith A, Harder T Journal article, Letter Registry Data Indicate a Meaningful Chance for Successful Pregnancies after Allogeneic Stem Cell Transplantation: Results from the German Stem Cell Transplant Registry (DRST) (2022) Sockel K, Frank S, Neu A, Ditschkowski M, Hilgendorf I, Goeckenjan M, Stoelzel F, et al. Conference contribution Trends in the Use of Hematopoietic Stem Cell Transplantation in the Management of Relapsed/Refractory Diffuse Large B Cell Lymphoma. a Retrospective Analysis of the Lymphoma Working Party of the EBMT (2022) Sureda A, Boumendil A, Berning P, Finel H, Caillot D, Rösler W, Finke J, et al. Conference contribution Efficacy of Ropeginterferon Alpha 2b in Inducing Treatment Free Remission in Chronic Myeloid Leukemia - an International, Randomized Phase III Trial (ENDURE, CML-IX) of the German CML-Study Group (2022) Burchert A, Saussele S, Michel C, Metzelder SK, Hochhaus A, Gattermann N, Crysandt M, et al. Conference contribution Treatment and Disease Characteristics of Chronic Myeloid Leukemia in Blast Crisis: The European Leukemianet Blast Crisis Registry (2022) Brioli A, Lomaia E, Fabisch C, Sacha T, Klamova H, Morozova E, Golos A, et al. Conference contribution Venetoclax-Based Salvage Therapy Improves Outcome in Relapsed/Refractory AML Patients Eligible for Intensive Treatment: A Propensity Score Matching Analysis (2022) Unglaub JM, Schlenk RF, Hanoun M, Reinhardt HC, Middeke JM, Schaefer-Eckart K, Steffen B, et al. Conference contribution